Literature DB >> 26223332

Sexual HIV risk among substance-using female commercial sex workers in Durban, South Africa.

Tara Carney1, Petal M Petersen Williams, Andreas Plüddemann, Charles D H Parry.   

Abstract

This study examined data collected from a sample of female sex workers (FSWs) during the first two years of a brief risk-reduction intervention for vulnerable populations that focused on substance use and HIV risk-related behaviours (2007-2009) as part of a rapid assessment and response evaluation study. In 2007, in collaboration with a local non-governmental organisation (NGO), an initiative was begun to roll out targeted harm reduction strategies for drug-using street based FSWs in Durban, South Africa. Data were collected on demographic characteristics, substance use and HIV risk behaviours to tailor these harm reduction strategies with participants. Over the first two years of the intervention, data were collected from 646 FSWs: 428 who reported being at low risk for HIV and 218 who reported being at high risk for HIV (defined as engaging in unprotected sex with sexual partners in the past 90 days). FSWs who had previously been diagnosed with HIV or a sexually transmitted disease (STD) were significantly less likely to report engaging in unprotected sex. Those who used over-the-counter or prescription (OTC/PRE) drugs reported engaging in unprotected sex significantly more often than FSWs who did not use these substances, while those who used heroin were less likely to report unprotected sex. The findings are encouraging in that those who are aware of their HIV status are less likely to engage in risky sexual behaviour, and therefore HIV testing and counselling is recommended. It indicates the need to identify strategies to encourage the likelihood of all FSWs, particularly those who are HIV-positive, to use condoms. It also encourages further research to investigate specific substances as possible predictors of high risk behaviours in high-risk populations of sex workers.

Entities:  

Keywords:  HIV sexual risk behaviours; drug use; sex work

Mesh:

Year:  2015        PMID: 26223332     DOI: 10.2989/16085906.2015.1040811

Source DB:  PubMed          Journal:  Afr J AIDS Res        ISSN: 1608-5906            Impact factor:   1.300


  6 in total

1.  Trajectories of initiation for the heroin-based drug whoonga - qualitative evidence from South Africa.

Authors:  Griffin A Tyree; Nzwakie Mosery; Elizabeth F Closson; Zonke Mabude; Carol du Toit; David R Bangsberg; Steven A Safren; Kenneth H Mayer; Jennifer A Smit; Matthew J Mimiaga; David J Grelotti
Journal:  Int J Drug Policy       Date:  2020-06-12

2.  Substance Use among Female Sex Workers in Two US-Mexico Border Cities: Associations with Age of Entry.

Authors:  Marissa Salazar; Kimberly C Brouwer; Teresita Rocha-Jimenez; Sabrina C Boyce; Hugo Staines-Orozco; Jay G Silverman
Journal:  Subst Use Misuse       Date:  2018-12-30       Impact factor: 2.164

3.  Is knowledge of HIV status associated with sexual behaviours? A fixed effects analysis of a female sex worker cohort in urban Uganda.

Authors:  Katrina F Ortblad; Daniel K Musoke; Thomson Ngabirano; Joshua A Salomon; Jessica E Haberer; Margaret McConnell; Catherine E Oldenburg; Till Bärnighausen
Journal:  J Int AIDS Soc       Date:  2019-07       Impact factor: 5.396

4.  Sexual transactions between long distance truck drivers and female sex workers in South Africa.

Authors:  Nosipho Faith Makhakhe; Tim Lane; James McIntyre; Helen Struthers
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

5.  Reducing substance use and risky sexual behaviour among drug users in Durban, South Africa: Assessing the impact of community-level risk-reduction interventions.

Authors:  C D H Parry; T Carney; P Petersen Williams
Journal:  SAHARA J       Date:  2017-12

6.  The role of health and advocacy organisations in assisting female sex workers to gain access to health care in South Africa.

Authors:  Nosipho Faith Makhakhe; Anna Meyer-Weitz; Helen Struthers; James McIntyre
Journal:  BMC Health Serv Res       Date:  2019-10-24       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.